Protagenic Therapeutics, Inc.\new Income (Loss) from Continuing Operations before Income Taxes, Domestic
Protagenic Therapeutics, Inc.\new (PTIX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $1.39 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-08-14.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-08-14
- Protagenic Therapeutics, Inc.\new income (loss) from continuing operations before income taxes, domestic for fiscal 2026 was $1.39M.
- Protagenic Therapeutics, Inc.\new income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$3.59M.
- Protagenic Therapeutics, Inc.\new income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$5.53M.
- Protagenic Therapeutics, Inc.\new income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$5.00M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2026-03-31 | $1.39M 10-K · filed 2026-08-14 |
| 2025-03-31 | -$3.59M 10-K · filed 2026-08-14 |
| 2024-12-31 | -$5.53M 10-K · filed 2025-03-31 |
| 2023-12-31 | -$5.00M 10-K · filed 2025-03-31 |
| 2022-12-31 | -$3.52M 10-K/A · filed 2024-05-14 |
| 2021-12-31 | -$4.52M 10-K · filed 2023-03-31 |
| 2020-12-31 | -$2.54M 10-K · filed 2022-04-07 |
| 2019-12-31 | -$1.70M 10-K · filed 2021-03-25 |
| 2018-12-31 | -$2.47M 10-K · filed 2020-04-29 |
| 2017-12-31 | -$2.13M 10-K · filed 2019-03-29 |
| 2016-12-31 | -$2.18M 10-K · filed 2018-04-02 |
| 2015-12-31 | -$747.69K 10-K/A · filed 2017-05-08 |
| 2014-12-31 | $16.00K 8-K/A · filed 2016-07-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |